These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21983063)

  • 21. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-gut microbiome interactions and functional bowel disorders.
    Mayer EA; Savidge T; Shulman RJ
    Gastroenterology; 2014 May; 146(6):1500-12. PubMed ID: 24583088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial flora as a cause or treatment of chronic diarrhea.
    Scaldaferri F; Pizzoferrato M; Pecere S; Forte F; Gasbarrini A
    Gastroenterol Clin North Am; 2012 Sep; 41(3):581-602. PubMed ID: 22917165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functions of intestinal microflora in children.
    Buccigrossi V; Nicastro E; Guarino A
    Curr Opin Gastroenterol; 2013 Jan; 29(1):31-8. PubMed ID: 23196853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microbiome in inflammatory bowel disease: current status and the future ahead.
    Kostic AD; Xavier RJ; Gevers D
    Gastroenterology; 2014 May; 146(6):1489-99. PubMed ID: 24560869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of probiotics in the treatment of inflammatory bowel diseases].
    Girardin M; Frossard JL
    Rev Med Suisse; 2012 Sep; 8(352):1674-6, 1678. PubMed ID: 22988728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.
    Seksik P; Sokol H; Lepage P; Vasquez N; Manichanh C; Mangin I; Pochart P; Doré J; Marteau P
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():11-8. PubMed ID: 16961738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
    Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
    Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The resilience of the intestinal microbiota influences health and disease.
    Sommer F; Anderson JM; Bharti R; Raes J; Rosenstiel P
    Nat Rev Microbiol; 2017 Oct; 15(10):630-638. PubMed ID: 28626231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics and prebiotics in chronic inflammatory bowel diseases.
    Ewaschuk JB; Dieleman LA
    World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review on prebiotics and probiotics for the control of dysbiosis: present status and future perspectives.
    Ducatelle R; Eeckhaut V; Haesebrouck F; Van Immerseel F
    Animal; 2015 Jan; 9(1):43-8. PubMed ID: 25336177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    DeGruttola AK; Low D; Mizoguchi A; Mizoguchi E
    Inflamm Bowel Dis; 2016 May; 22(5):1137-50. PubMed ID: 27070911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Debugging the intestinal microbiota in IBD.
    Dessein R; Rosenstiel P; Chamaillard M
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S131-6. PubMed ID: 20117336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota and the role of probiotics in therapy.
    Quigley EM
    Curr Opin Pharmacol; 2011 Dec; 11(6):593-603. PubMed ID: 21996283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
    Andoh A; Fujiyama Y
    World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease: role of diet, microbiota, life style.
    Neuman MG; Nanau RM
    Transl Res; 2012 Jul; 160(1):29-44. PubMed ID: 22687961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.